The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics
- PMID: 33341485
- PMCID: PMC7831651
- DOI: 10.1016/j.jiph.2020.10.018
The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics
Abstract
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China in December 2019 and is associated with high levels of morbidity and mortality. Various types of bacterial and fungal infections occur in patients with COVID-19 with some resistant to antimicrobials that are associated with significantly worse outcomes and deaths. Besides, antimicrobial-resistant (AMR) co-infections are responsible for clinically significant mortality in past pandemics. There is evidence to suggest that factors such as the proliferation of adulterated antimicrobials in some developing countries, international travels, issues with healthcare financing, use/misuse by humans, and in agricultural production and climate change are determinants of AMR at various levels of society. These complex interrelated determinants intersect with AMR in current and past pandemics and could amplify the potential of a future antimicrobial resistance pandemic. Therefore, global concerted interventions targeted at all levels of society to reduce the use/misuse of antimicrobials and disrupt these multifaceted, interrelated, and interdependent factors are urgently needed. This paper leverages prior research to describe complex major determinants of antimicrobial resistance and provides fresh insights into possible intervention strategies to tackle antimicrobial resistance including in the current and future pandemics.
Keywords: Antibiotics; Antimicrobial resistance; Determinants; Infections; Pandemics.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Figures
References
-
- CDC . Centers for Disease Control and Prevention; 2017. Life expectancy.https://www.cdc.gov/nchs/fastats/life-expectancy.htm
-
- Piddock L.J. The crisis of no new antibiotics—what is the way forward? Lancet Infect Dis. 2012;12(3):249–253. - PubMed
-
- Rossolini G.M., Arena F., Pecile P., Pollini S. Update on the antibiotic resistance crisis. Curr Opin Pharmacol. 2014;18:56–60. - PubMed
-
- Butler M.S., Buss A.D. Natural products—the future scaffolds for novel antibiotics? Biochem Pharmacol. 2006;71(7):919–929. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous